G

ood morning, one and all. Damian Garde here, filling in for Ed Silverman in the winnowing work hours of yet another week. Any expectation of a requisite news-light August has long since been turned on its head, requiring ever more cups of stimulation and perhaps the occasionally pinch to ensure one hasn’t slipped into a dream. Here’s your regular serving of headlines to get the day going, and please do send us a note if you hear anything interesting.

Two Democratic lawmakers are demanding answers on the escalating prices of multiple sclerosis drugs, STAT tells us. Reps. Elijah Cummings of Maryland and Peter Welch of Vermont sent a letter to the seven largest makers of such treatments — including Biogen (BIIB), Roche (ROG), and Bayer (BAYN) — to request documents on how they set their prices, seeking answers as to how the average cost of MS therapy has nearly quadrupled since 2004.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • NO MS drugs have ever cured MS and never ever will. Billions upon billions has been made from MS patients who have all been exploited for money. Many MS drugs are poisons and many have died on MS drugs that still no one yet has collected all the data on. Sadly many more will die because no one has scrutinized whats really going on sadly .

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy